Visit
The 2nd Society of Hematological Oncology (SOHO) Italian three-day meeting brings together leading SOHO experts and Italian researchers in acute leukemias, MPNs, and MDS, with the aims of consolidating the Italian Hematology-SOHO partnership.
Highlights from this year’s SOHO Italy Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.
SOHO Italy 2020
This analysis was published recently in @BloodJournal
A BIG thank you for the worlwide collaboration that made possible one of the largest MRD studies in myeloma #mmsm
https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2022016782/486677/MRD-dynamics-during-maintenance-for-improved/ https://twitter.com/VJHemOnc/status/1575380146521083906
🎥 @BrunoPaiva_UNAV discusses the results of a pooled analysis of the TOURMALINE-MM3 and MM4 trials at #IMS2022:
👉http://ow.ly/iHYt50KVQEy👈
@Myeloma_Society #MMsm #HemOnc #mmMRD #BloodCancerAwarenessMonth
We spoke to @adamssperling (@DanaFarber), who shared some insights into the role of clonal hematopoiesis in multiple myeloma and other hematological malignancies:
🎥: http://ow.ly/GGiK50KVRjM
#MMsm #HemOnc #BloodCancerAwarenessMonth #IMS2022
Great discussion today, thanks Jorge, see you in Mandelieu for ESH CML meeting https://twitter.com/vjhemonc/status/1575582501913100288
A great session we had here today at #SOHO22 with CML experts Jorge Cortes (@GCC_Cortes) & Mhairi Copland (@CoplandMhairi)!
Stay tuned for more of our expert-led discussions!
@SocietyofHemOnc #SOHO2022 #HemOnc #LeuSM #CMLsm
SOHO Italy 2020
The 2nd Society of Hematological Oncology (SOHO) Italian three-day meeting brings together leading SOHO experts and Italian researchers in acute leukemias, MPNs, and MDS, with the aims of consolidating the Italian Hematology-SOHO partnership.
Highlights from this year’s SOHO Italy Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.
This analysis was published recently in @BloodJournal
A BIG thank you for the worlwide collaboration that made possible one of the largest MRD studies in myeloma #mmsm
https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2022016782/486677/MRD-dynamics-during-maintenance-for-improved/ https://twitter.com/VJHemOnc/status/1575380146521083906
🎥 @BrunoPaiva_UNAV discusses the results of a pooled analysis of the TOURMALINE-MM3 and MM4 trials at #IMS2022:
👉http://ow.ly/iHYt50KVQEy👈
@Myeloma_Society #MMsm #HemOnc #mmMRD #BloodCancerAwarenessMonth
We spoke to @adamssperling (@DanaFarber), who shared some insights into the role of clonal hematopoiesis in multiple myeloma and other hematological malignancies:
🎥: http://ow.ly/GGiK50KVRjM
#MMsm #HemOnc #BloodCancerAwarenessMonth #IMS2022
Great discussion today, thanks Jorge, see you in Mandelieu for ESH CML meeting https://twitter.com/vjhemonc/status/1575582501913100288
A great session we had here today at #SOHO22 with CML experts Jorge Cortes (@GCC_Cortes) & Mhairi Copland (@CoplandMhairi)!
Stay tuned for more of our expert-led discussions!
@SocietyofHemOnc #SOHO2022 #HemOnc #LeuSM #CMLsm
VJHemOnc is intended for Healthcare Professionals onlyBy choosing to continue, you are confirming that you are a healthcare professional
Sign-up for our Newsletter!
Keep up to date with all the latest news with our monthly newsletter
